Qianjiang Yongan Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 712.125 million compared to CNY 581.310 million a year ago. Operating income was CNY 56.520 million compared to CNY 114.043 million a year ago. Net income was CNY 47.225 million compared to CNY 93.909 million a year ago. Basic earnings per share from continuing operations was CNY 0.16 compared to CNY 0.33 a year ago.